Global Pharma Regulatory Management Systems Market to Reach $1.74 Billion by 2027 at a CAGR 14.1% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharma Regulatory Management Systems Market Research Report by Component (Services and Solution), Deployment, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Pharma Regulatory Management Systems Market size was estimated at USD 787.00 million in 2021, USD 896.00 million in 2022, and is projected to grow at a CAGR 14.10% to reach USD 1,737.02 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pharma Regulatory Management Systems to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Component, the market was studied across Services and Solution. The Services is further studied across Managed Services and Professional Services. The Solution is further studied across IDMP/Compliance Management, Regulatory Information Management, and Regulatory Submissions Management System.
• Based on Deployment, the market was studied across On-Cloud and On-Premises.
• Based on End User, the market was studied across Government Agencies, Hospitals & Care Providers, and Pharmaceutical & Biotechnology Companies.
• Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharma Regulatory Management Systems Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Pharma Regulatory Management Systems Market, by Component

7. Pharma Regulatory Management Systems Market, by Deployment

8. Pharma Regulatory Management Systems Market, by End-user

9. Americas Pharma Regulatory Management Systems Market

10. Asia-Pacific Pharma Regulatory Management Systems Market

11. Europe, Middle East & Africa Pharma Regulatory Management Systems Market

12. Competitive Landscape

13. Company Usability Profiles

14. Appendix

Companies Mentioned

• Acolad Group
• Acuta, LLC
• Antares Vision
• ArisGlobal LLC
• arivis AG By BioMedion AG
• Computer Sciences Corp
• Dassault Systemes SE
• DDi, Inc
• Dovel Technologies, Inc.
• Ennov SA
• EXTEDO
• Freyr
• Glemser Technologies Corporation
• GlobeMed Ltd
• Health Business Systems Inc.
• Honeywell International Inc
• Idhasoft Ltd
• Informa PLC
• Instem
• MasterControl, Inc.
• MedHOK Inc.
• NNIT
• Parexel International
• pharmaREADY
• Qualityze Inc
• Veeva Systems
• Virtify, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/rjo9c

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900